{"url":"https://lda.senate.gov/api/v1/filings/d68ce6f4-f116-4ccf-8bca-80a8de856433/","filing_uuid":"d68ce6f4-f116-4ccf-8bca-80a8de856433","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2010,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d68ce6f4-f116-4ccf-8bca-80a8de856433/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Theodore Bornstein, Attorney","dt_posted":"2010-04-19T17:56:03.477000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"3000 K ST NW, Suite 500","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20007","registrant":{"id":15042,"url":"https://lda.senate.gov/api/v1/registrants/15042/","house_registrant_id":33563,"name":"FOLEY & LARDNER LLP","description":"law firm","address_1":"3000 K Street NW","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20007","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JARED B. RIFIS","contact_telephone":"+1 202-295-4154","dt_updated":"2026-07-30T15:10:39.292701-04:00"},"client":{"id":120688,"url":"https://lda.senate.gov/api/v1/clients/120688/","client_id":1004696,"name":"ROMARK LABORATORIES, LC","general_description":"Biotechnology development","client_government_entity":false,"client_self_select":false,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-11-24"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Sale of new anti-viral drug","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43539,"prefix":"mr","prefix_display":"MR.","first_name":"SCOTT","nickname":null,"middle_name":"L","last_name":"KLUG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10833,"prefix":"mr","prefix_display":"MR.","first_name":"THEODORE","nickname":null,"middle_name":"H","last_name":"BORNSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Sale of new anti-viral drug","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43539,"prefix":"mr","prefix_display":"MR.","first_name":"SCOTT","nickname":null,"middle_name":"L","last_name":"KLUG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10833,"prefix":"mr","prefix_display":"MR.","first_name":"THEODORE","nickname":null,"middle_name":"H","last_name":"BORNSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}